These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26698166)

  • 1. Mechanism governing heme synthesis reveals a GATA factor/heme circuit that controls differentiation.
    Tanimura N; Miller E; Igarashi K; Yang D; Burstyn JN; Dewey CN; Bresnick EH
    EMBO Rep; 2016 Feb; 17(2):249-65. PubMed ID: 26698166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation.
    Zhang Y; Zhang J; An W; Wan Y; Ma S; Yin J; Li X; Gao J; Yuan W; Guo Y; Engel JD; Shi L; Cheng T; Zhu X
    Nucleic Acids Res; 2017 Jan; 45(2):657-671. PubMed ID: 28123038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering How Heme Controls Genome Function Through Heme-omics.
    Liao R; Zheng Y; Liu X; Zhang Y; Seim G; Tanimura N; Wilson GM; Hematti P; Coon JJ; Fan J; Xu J; Keles S; Bresnick EH
    Cell Rep; 2020 Jun; 31(13):107832. PubMed ID: 32610133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA/Heme Multi-omics Reveals a Trace Metal-Dependent Cellular Differentiation Mechanism.
    Tanimura N; Liao R; Wilson GM; Dent MR; Cao M; Burstyn JN; Hematti P; Liu X; Zhang Y; Zheng Y; Keles S; Xu J; Coon JJ; Bresnick EH
    Dev Cell; 2018 Sep; 46(5):581-594.e4. PubMed ID: 30122630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
    Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S
    Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the murine erythroid-specific 5-aminolevulinate synthase gene.
    Kramer MF; Gunaratne P; Ferreira GC
    Gene; 2000 Apr; 247(1-2):153-66. PubMed ID: 10773455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine erythroid 5-aminolevulinate synthase: Truncation of a disordered N-terminal extension is not detrimental for catalysis.
    Stojanovski BM; Breydo L; Uversky VN; Ferreira GC
    Biochim Biophys Acta; 2016 May; 1864(5):441-52. PubMed ID: 26854603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes.
    Liao R; Bresnick EH
    Exp Hematol; 2024 Sep; 137():104252. PubMed ID: 38876253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a cell-type-specific genetic network by the mediator complex component Med1.
    Pope NJ; Bresnick EH
    Mol Cell Biol; 2013 May; 33(10):1938-55. PubMed ID: 23459945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
    Sadlon TJ; Dell'Oso T; Surinya KH; May BK
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1153-67. PubMed ID: 10582344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
    Tahara T; Sun J; Igarashi K; Taketani S
    Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a hematopoietic genetic network through locus-specific integration of chromatin regulators.
    DeVilbiss AW; Boyer ME; Bresnick EH
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3398-407. PubMed ID: 23959865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Role of Human ALAS2 C-terminal Mutations Resulting in Loss of Function and Disease.
    Taylor JL; Ayres-Galhardo PH; Brown BL
    Biochemistry; 2024 Jul; 63(13):1636-1646. PubMed ID: 38888931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme as a differentiation-regulatory transcriptional cofactor.
    Liao R; Bresnick EH
    Int J Hematol; 2022 Aug; 116(2):174-181. PubMed ID: 35776402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell biology of heme.
    Ponka P
    Am J Med Sci; 1999 Oct; 318(4):241-56. PubMed ID: 10522552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis.
    Wozniak RJ; Keles S; Lugus JJ; Young KH; Boyer ME; Tran TM; Choi K; Bresnick EH
    Mol Cell Biol; 2008 Nov; 28(21):6681-94. PubMed ID: 18779319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.
    Furuyama K; Sassa S
    J Clin Invest; 2000 Mar; 105(6):757-64. PubMed ID: 10727444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroleukemia differentiation. Distinctive responses of the erythroid-specific and the nonspecific delta-aminolevulinate synthase mRNA.
    Fujita H; Yamamoto M; Yamagami T; Hayashi N; Sassa S
    J Biol Chem; 1991 Sep; 266(26):17494-502. PubMed ID: 1894633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.